ReShape Lifesciences Inc. (NASDAQ:RSLS) Sees Significant Growth in Short Interest

ReShape Lifesciences Inc. (NASDAQ:RSLS) was the target of a large increase in short interest during the month of March. As of March 31st, there was short interest totalling 688,700 shares, an increase of 87.6% from the March 15th total of 367,200 shares. Based on an average trading volume of 8,870,000 shares, the short-interest ratio is currently 0.1 days. Approximately 7.5% of the company’s shares are short sold.

ReShape Lifesciences Trading Down 4.4 %

Shares of NASDAQ:RSLS opened at $0.36 on Thursday. The company has a market cap of $4.09 million, a price-to-earnings ratio of -0.03 and a beta of 1.59. ReShape Lifesciences has a 12 month low of $0.30 and a 12 month high of $29.00. The company has a 50-day moving average price of $0.95 and a 200-day moving average price of $3.59.

ReShape Lifesciences (NASDAQ:RSLS) last issued its quarterly earnings data on Friday, April 4th. The medical device company reported ($1.89) earnings per share for the quarter, topping analysts’ consensus estimates of ($4.06) by $2.17. The firm had revenue of $1.81 million for the quarter, compared to analyst estimates of $3.17 million. ReShape Lifesciences had a negative return on equity of 179.83% and a negative net margin of 86.36%. During the same period last year, the company earned ($110.87) EPS.

About ReShape Lifesciences

ReShape Lifesciences Inc provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus.